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Development of rhamnose-rich hydrogels based on sulfated xylorhamno-uronic
acid toward wound healing applications
Abstract
An array of biological properties is demonstrated in the category of extracts broadly known as ulvans,
including antibacterial, anti-inflammatory and anti-coagulant activities. However, the development of this
category in biomedical applications is limited due to high structural variability across species and a lack
of consistent and scalable sources. In addition, the modification and formulation of these molecules is
still in its infancy with regard to progressing to product development. Here, a sulfated and rhamnose-rich,
xylorhamno-uronic acid (XRU) extract from the cell wall of a controlled source of cultivated Australian
ulvacean macroalgae resembles mammalian connective glycosaminoglycans. It is therefore a strong
candidate for applications in wound healing and tissue regeneration. This study targets the development
of polysaccharide modification for fabrication of 3D scaffolds for skin cell (fibroblast) culture. The XRU
extract is methacrylated and UV-crosslinked to produce hydrogels with tuneable mechanical properties.
The hydrogels demonstrate high cell viability and support cell proliferation over 14 days, which are far
more functional than comparable alginate gels. Importantly, an XRU-based bioink is developed for
extrusion printing 3D constructs both with and without cell encapsulation. These results highlight the
close to product potential of this rhamnose-rich XRU extract as a promising biomaterial toward wound
healing. Future studies should be focused on in-depth in vitro characterizations to examine the role of the
material in dermal extracellular matrix (ECM) secretion of 3D printed structures, and in vivo
characterizations to assess its capacity in supporting wound healing.
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Abstract
An array of biological properties is demonstrated in the category of extracts broadly known as ulvans,
including antibacterial, anti-inflammatory and anti-coagulant activities. However, the development
of this category in biomedical applications is limited due to high structural variability across species
and a lack of consistent and scalable sources. In addition, the modification and formulation of these
molecules is still in its infancy with regard to progressing to product development. Here, a sulfated
and rhamnose-rich, xylorhamno-uronic acid (XRU) extract from the cell wall of a controlled source
of

cultivated,

Australian

ulvacean

macroalgae

resembles

mammalian

connective

glycosaminoglycans. It is therefore a strong candidate for applications in wound healing and tissue
regeneration. This study targets the development of polysaccharide modification for fabrication of
3D scaffolds for skin cell (fibroblast) culture. The XRU extract is methacrylated and UV-crosslinked
to produce hydrogels with tuneable mechanical properties. The hydrogels demonstrate high cell
viability and support cell proliferation over 14 days, which are far more functional than comparable
alginate gels. Importantly, an XRU-based bioink is developed for extrusion printing 3D constructs
both with and without cell encapsulation. These results highlight the close to product potential of this
rhamnose-rich XRU extract as a promising biomaterial toward wound healing. Future studies should
be focused on in-depth in vitro characterizations to examine the role of the material in dermal
extracellular matrix (ECM) secretion of 3D printed structures, and in vivo characterizations to assess
its capacity in supporting wound healing.
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Introduction
Ulvacean macroalgae are infamously associated with green tide phenomena and have been explored
extensively as a potential renewable and economic biomass resource.1 A key area of interest has been
the utilization of the cell wall polysaccharides, which are broadly known as ulvans. Ulvans are
naturally sulfated and demonstrate a number of biological activities.2 In particular ulvans exhibit a
similarity to the glycosaminoglycan polysaccharides in mammalian tissue; specifically dermatan
sulfate and chondroitin sulfate.2,3 The fabrication of new biomaterials that might take advantage of
this similarity should enable applications in tissue regeneration or wound healing. To date early
research is promising yet underdeveloped.3,4 This is largely due to high variability of the chemical
structure and composition across species and a lack of consistent and scalable sources.2,5 Further,
fabrication into functional materials will require a number of processes, including for example
structural modification to enable stable gel formation and transfer to scalable fabrication processes,
and consistency of function through all of the stages.

Ulvan constitutes primarily monosaccharide units of rhamnose, xylose and uronic acids, and sulfates.
Structurally, ulvan is dominated by repeating disaccharide units, where uronic acid, either Dglucuronic acid or L-iduronic acid, or D-xylose is linked to L-rhamnose-3-sulfate through 1, 4glycosidic bonds.2,5 Sulfate groups exist typically in the L-rhamnose units at the position C3 or in the
D-xylose units.5 In comparison with other algal polysaccharide categories such as alginate6 and
fucoidan7 from phaeophycean seaweeds, and carrageenan from rhodophycean red seaweed,8 ulvan is
unique in its L-rhamnose-rich structure. Further there is a high degree of variability in the molecular
ratio of rhamnose in ulvans from different species.9 Studies have shown that L-rhamnose-binding
lectins are present on the cell membranes of human skin fibroblasts and keratinocytes whose cellular
activities can be regulated by L-rhamnose-lectin interactions.10,11 Further, ulvan contains Dglucuronic acid and its epimer L-iduronic acid units, resembling the mammalian glycosaminoglycans
(GAGs) that are found in human skin extracellular matrix (ECM), such as heparin, heparan sulfate,
3

dermatan sulfate and hyaluronic acid.2 These mammalian GAGs play vital roles in regulating cellular
events associated with wound healing.12 It is for these properties that ulvans are considered a potential
analogue to natural GAGs (Fig. 1), that include binding, structural support and protection of protein
ligands such as collagen, growth factors and cytokines, with the benefits of increased stability13 in a
proteolytic environment like a wound and avoidance of animal sources in medical devices. Lastly,
ulvan exhibits diverse biological activities such as antibacterial, antiviral, anti-inflammatory and
anticoagulant activities.2 With this combination of features, ulvan makes a strong candidate for the
application in wound healing.

Conditions of chronic wounds necessitate clinical intervention to accelerate wound healing
processes.14 To this end, skin grafts and bioengineered skin substitutes have been developed. While
traditional skin grafts have their inherent limitations,14 skin tissue engineering offers wider options
and have already delivered many skin substitutes for clinical use.15 However, these skin products also
face miscellaneous problems arising from the use of animal-derived biomaterials, such as collagen
and decellularized skin tissue etc. The potential safety concern raised by these biomaterials is
considered as the first issue coming before their mechanical weakness and lack of long-term
biostability.16,17 In this respect, algae-derived biomaterials, such as alginate, have already been
developed into wound healing products due to low immunogenicity and versatile properties.6
However, alginate is primarily used in passive wound dressings to absorb excessive exudates,18 due
to its poor cell-matrix interactions.19

The water-soluble extract used in this study is a rhamnose-rich xylorhamno-uronic acid (XRU) that
is extracted from a genetically barcoded species of Australian ulvacean macroalgae. The objective of
this work is to provide a foundation for our ongoing research program to develop marine-based
bioprinting platforms for wound healing applications. Specifically, we address the limitations in the
modification and formulation of XRU with regard to progressing to product development. XRU was
4

modified by methacrylation, and then photo-crosslinked to produce XRU hydrogels. The hydrogels
were assessed in terms of physicochemical properties and cytocompatibility against a relevant cell
model, human dermal fibroblasts (HDFs). To enable fabrication of 3D XRU-based structures in a
spatially controlled manner, a XRU-based bioink was developed for 3D extrusion printing. Both 3D
printed hydrogel scaffolds and cell-laden constructs were developed with excellent cytocompatibility
with HDFs. These results highlight the potential of this sulfated, rhamnose-rich XRU extract as a
promising biomaterial toward wound healing applications.

Materials and methods
Materials
The sulfated, rhamnose-rich xylorhamno-uronic acid (XRU) extract (PhycoDerm™) with a molecular
weight of > 600 kDa was provided by Venus Shell Systems Pty. Ltd. (VSS, Australia). The proximate
composition and key characteristics are provided in Table 1. N,N-dimethylformamide (DMF),
ethanol, sodium hydroxide and calcium chloride dihydrate were purchased from Chem-Supply.
Methacrylic anhydride, deuterium oxide (D2O), alginic acid sodium salt (4-12 cP, 1 % in H2O, 25
°C), gelatin from porcine skin (gel strength 300, Type A) and lithium phenyl-2, 4, 6trimethylbenzoylphosphinate (LAP) were purchased from Sigma-Aldrich. All reagents were used as
received.

Modification of the XRU extract with methacrylic anhydride
Methacrylation of the XRU extract was conducted using a method previously described1,20 with some
minor modification. Briefly, the XRU extract was dissolved in a binary solvent system composed of
Milli-Q water and DMF (50/50, v/v), followed by the addition of methacrylic anhydride (MA, 5 molar
equivalents of disaccharide repeating units of XRU). The reaction mixture was stirred at room
temperature, and the pH was maintained at 8.0-8.5 for the first 2 h by the addition of 5 M NaOH. The
reaction mixture was then stirred for another 22 h at room temperature before being precipitated into
5

ethanol. The precipitate was collected by centrifugation, redissolved in deionized water, dialysed
against deionized water for 48 h, and then lyophilized. The methacrylated XRU extract (XRU-MA)
was stored at -20 °C for further analysis.

Structural characterization was performed by Fourier Transform Infrared Spectroscopy (FT-IR) and
1

H nuclear magnetic resonance (NMR). FT-IR spectra were recorded in the range of 4000–700 cm-1

at a resolution of 4 cm-1 on an IRPrestige-21 spectrometer (Shimadzu, Japan) attached with an
attenuated total reflection (ATR) component. Prior to FT-IR analysis, the sample was dried in a
vacuum oven at 40 °C overnight. 1H NMR spectra were recorded in D2O at 60 °C using a Bruker
Avance III 400 MHz spectrometer (Bruker, Germany). The degree of substitution (DS), defined as
the average number of introduced methacrylate group per XRU disaccharide unit, was estimated
approximately by 1H NMR by calculating the ratio of integration areas of proton peaks from the
methacrylate groups to that of the methyl groups of the L-rhamnose in the polymer backbone.1,21

Preparation of molded XRU hydrogels
XRU-MA was dissolved in phosphate buffered saline (PBS) at various concentrations (5%, 7.5% or
10%, w/v). LAP was added to each solution at a final concentration of 0.06% (w/v). Then, XRU
hydrogels were prepared in an acrylic mold (8 mm diameter, 1.5 mm thickness) via photocrosslinking using a Lumen Dynamics OmniCure LX400+ (400 nm light source) at various photoexposure energies (792, 1524 or 2220 mJ). The hydrogel was washed with deionized water for 48 h
to remove any un-crosslinked polymer residue.

For in vitro cell culture, alginate hydrogels and collagen-coated XRU hydrogels were also prepared
for comparison. Alginate hydrogels (8 mm diameter, 1.5 mm thickness) were prepared by
crosslinking of an aqueous solution of alginic acid sodium salt (2% w/v) in calcium chloride (2%
w/v) for 10 min. For preparation of collagen-coated XRU hydrogels, the molded XRU scaffolds were
6

freeze-dried and saturated with a collagen solution (Type I, 0.5 mg mL-1 in PBS) at 37 ºC overnight.
Then the coated hydrogels were washed with PBS to remove un-bound collagen.

Physicochemical characterization of the molded XRU hydrogels
Mechanical properties. Mechanical test by micro-indentation was carried out using an EZ-S
mechanical tester (Shimadzu, Japan) in the compression mode with a 10 N load cell at a cross-head
speed of 0.1 mm min-1. The Young’s modulus (E2) of the sample was calculated using Equation (1).22

F = 8/3rE2d

(1)

where F is the force applied to the hydrogel sample, r is the radius (0.495 mm) of the indenter tip, and
d is the indentation depth. The data collected were linearly regressed by plotting the applied force
against the indentation depth. The gradient of the linear regression was then used for the calculation.

Water uptake capacity. Samples of the molded XRU hydrogels were freeze-dried and their dry
weights (Wi) were recorded before being re-immersed in deionized water. At predetermined intervals
of 3, 8, 11 and 24 h, the swollen hydrogels were dabbed dry with Kimwipes to remove surface water
and the hydrated weights (Ws) were recorded at each time point. The equilibrium water content and
water uptake capacity were calculated using Equation (2) and (3), respectively.

Water content (%) = (Ws – Wi)/Ws × 100

(2)

Water uptake capacity (%) = (Ws – Wi)/Wi × 100
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(3)

Microstructure. The microstructure of the XRU hydrogels was characterized using a scanning
electron microscope (SEM, JEOL JSM-6490LV, Japan). The hydrogels were freeze-dried, coated
with platinum (15 nm) using a Dynavac sputter coater and observed under an accelerating voltage of
15 kV.

In vitro cell culture of HDFs on the molded XRU hydrogels
HDFs obtained from Cell Applications, Inc. (San Diego, CA, USA) were used at passages 10-15 in
the study. Cells were routinely maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, SigmaAldrich) supplemented with 10% (v/v) fetal bovine serum (FBS, Invitrogen™) and 1% (v/v)
penicillin-streptomycin (10,000 U mL-1, Gibco™) in a 5% CO2 humidified incubator at 37 °C. For in
vitro cell culture, all the hydrogel scaffolds used in this study were freeze-dried and UV sterilized.

Cytocompatibility of the XRU hydrogels was assessed by live/dead staining. Alginate hydrogels were
employed for comparison. Briefly, HDFs were seeded at a density of 0.5 × 106 cells per scaffold and
incubated with 1 mL cell culture medium. At day 1 and 7 post cell seeding, the cell-seeded hydrogels
were incubated with calcein AM (5 µg mL-1) in the culture medium for 25 min, and then propidium
iodide (PI, 1 µg mL-1) in the culture medium for 5 min. The hydrogels were washed with PBS and
cell culture medium. Images of live (green) and dead (red) cells were acquired using a confocal laser
scanning microscope (CLSM, Leica TSC SP5 II).

Proliferation of HDFs cultured on the XRU hydrogels was evaluated using Quant-iT™ PicoGreen™
dsDNA assay (Thermo Fisher Scientific). The alginate hydrogels and collagen-coated XRU
hydrogels were used as negative and positive controls, respectively. For each type of scaffolds, nonseeded hydrogels were used as blank controls. At predetermined time points, cell-seeded hydrogels
and cell-free hydrogels were collected, broken up using a spatula and analyzed following the
manufacturer’ protocol. The fluorescence reading was recorded using a microplate reader
8

(POLARstar Omega) at an excitation wavelength of 485 nm and an emission wavelength of 520 nm.
Cell number in each scaffold was determined using a standard calibration curve established with serial
cell lysates of known cell numbers.

Cell morphology of the HDFs cultured on the XRU hydrogels was analyzed by F-actin staining. The
cells were fixed in 3.7% paraformaldehyde for 10 min and permeabilized with 0.1% Triton X-100 for
5 min at room temperature. Then the samples were stained with Alexa FluorTM 488 phalloidin
(Invitrogen™, Life Technologies) in 1% bovine serum albumin (BSA, 1:40, v/v) for 50 min and
counterstained with 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI, 1 µg mL-1 in PBS)
(Invitrogen™, Life Technology) for 10 min, then washed with PBS and imaged using CLSM. HDF
morphology was also examined by SEM. After fixation, the samples were dehydrated in a graded
ethanol series (30%, 50%, 70%, 90% and 100%) for 30 min at each concentration, freeze-dried and
coated with platinum for SEM observation.

Bioink formulation and rheology characterization
A composite bioink was formulated in PBS comprising 10% (w/v) XRU-MA, 5% (w/v) gelatin and
1% (v/v) penicillin-streptomycin. LAP was then added to a final concentration of 0.06% (w/v). The
rheological properties of the bioink were characterized on an AR-G2 Rheometer (TA Instruments)
using a 15 mm plate geometry with a 2° cone, fitted with a Peltier temperature controlled stage. The
geometry gap between plates was set to 55 μm. Temperature sweep was conducted from 40 °C to 8
°C at a ramp rate of 1.5 °C min-1, 1 Hz frequency and 1% strain. The sample was loaded at 37 °C and
equilibrated for 2 min prior to the temperature sweep measurement. Viscometry was performed at 23
°C and 15 °C respectively with the shear rates ranging from 0.1 to 1000 s-1. The sample was allowed
to gel at room temperature (22-23 °C) before loading onto the Peltier plate at 23 °C. A conditioning
step with 5 min pre-shear at a shear rate of 5 s-1 and 5 min equilibrium both at 23 °C was applied
before viscosity measurement.
9

3D printing (cell-containing) XRU-based hydrogels
Cell-free XRU-MA constructs were firstly fabricated by extrusion printing in a layer-by-layer fashion
using a 3D Bioplotter (EnvisionTEC, Germany). The printer is housed within a biosafety cabinet to
ensure sterility. All printing was conducted at 23 °C with the substrate set to 15 °C. The printing
pressure and speed was 3.5 bar and 10 mm s-1, respectively. An extrusion needle of 200 µm in
diameter was used. A cuboid, 4-layered scaffold (10 × 10 mm) was designed, exported as a Standard
Tessellation Language (STL) file and sliced using the Bioplotter RP® software. The infill of scaffolds
was set to angles of 0° and 90°, with a print height of 0.130 mm and line space of 1.0 mm in the
Virtual Machines software (EnvisionTEC, Germany). Once printed, the scaffolds were crosslinked
with 400 nm light for 60 s (792 mJ). The printed scaffolds were incubated in the culture medium of
HDFs at 37 °C for more than two days to remove the entrapped gelatin, freeze-dried and UV sterilized
for 30 minutes on each side. The 3D printed scaffolds were then seeded with HDFs, and live/dead
staining and cell proliferation assay were performed using the same procedure as detailed above.

For cell printing, HDFs were loaded to the bioink at a cell density of 1 × 106 mL-1, and the cell-laden
XRU-based constructs were printed using the same procedure as described above. Upon printing, the
3D-printed cell-laden constructs were crosslinked with 400 nm light for 60 s (792 mJ), and incubated
in the culture medium. Live/dead staining was performed at day 1 and day 7 post the printing.

Statistical Analysis
Data were presented as mean ± standard deviation (SD), where n ≥ 3. Statistically significant
differences were obtained using Student’s t-test (two-tailed). Values with p < 0.05 and p < 0.001
indicating significant and very significant differences separately were denoted as “*” and “**”
respectively in the figures.
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Results and discussion
Structural characterization of the modified XRU extract
The present study aims to provide a foundation for our ongoing research program to develop marinederived bioprinting platforms for wound healing application. XRU is readily soluble in water, for
which modification is required to render the structures stable in physiologically relevant conditions.
A photo-crosslinkable XRU was developed by reacting XRU with methacrylic anhydride (Fig. 2A).
Here a binary solvent of Milli-Q water and DMF (50/50, v/v) was employed, as it has been previously
shown to improve the efficacy of methacrylation as a result of improved solubility of methacrylic
anhydride in the reaction system.20,23

The modified structure of XRU was verified by FT-IR (Fig. 2B) and 1H NMR (Fig. 2C). In the FTIR spectra, the peak at ~1713 cm-1 for XRU-MA, not found in the spectrum of the unmodified XRU
extract, corresponded to the stretching vibration of C=O from the conjugated ester linkage. In the 1H
NMR spectra, methacrylation of the XRU extract was demonstrated by the appearance of distinctive
peaks in the double bond region (between 5.8 and 6.8 ppm) and a sharp peak that corresponded to the
-CH3 of the methacrylate groups (2.3 ppm). The estimated degree of methacrylation was ~0.8-0.9 per
XRU disaccharide unit.

Physicochemical properties of the molded XRU hydrogels
XRU hydrogels were prepared by photo-crosslinking and subjected to mechanical and water-uptake
studies. The mechanical property of the XRU hydrogels prepared with various XRU-MA
concentrations (5%, 7.5%, or 10%, w/v) and photo-crosslinking energies (792-2220 mJ) showed
Young’s moduli ranging from ~18 kPa to ~309 kPa (Fig. 3A). The Young’s modulus increased with
increasing the XRU-MA concentration and photo-crosslinking energy. For example, the Young’s
modulus of the XRU hydrogels crosslinked with a photo energy of 792 mJ increased from ~18 kPa
to ~182 kPa when the polymer concentration increased from 5% to 10% (p < 0.001, Fig. 3A).
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Increasing the photo-exposure energy from 792 mJ to 2220 mJ resulted in a 2.5, 1.7 and 1.7-fold
increase in the Young’s modulus of 5%, 7.5% and 10% XRU hydrogels, respectively. These
correlations may result from an increase in crosslinking density as a result of higher concentrations
of macromer and/or photo energy. Our results demonstrated that the Young’s modulus of an XRU
hydrogel can be easily tailored by manipulating polymer concentration and photo-crosslinking
condition.

The water uptake capacity of a hydrogel is important for the targeted application in wound healing as
the moisture level in a wound area is critical for the healing process.24-26 The XRU hydrogels
demonstrated a high capacity to uptake and retain water, with ~30-80-fold increases in weight within
24 hours’ hydration at room temperature (Fig. 3B). These samples reached their respective
equilibrium water contents (> 96%) in less than 3 hours (Fig. 3C). Here, the samples prepared from
5% XRU-MA and crosslinked with a photo energy of 792 mJ were not included, as they were too
fragile to maintain structural integrity during the course of study. Amongst the three groups,
increasing the polymer concentration resulted in a small but significant reduction in the equilibrium
water content. For instance, the equilibrium water content of the XRU hydrogels exposed to 1524 mJ
decreased from 98.8% to 96.8% when the polymer concentration increased from 5% to 10% (p <
0.001, Fig. 3C). Within each group, the equilibrium water content decreased slightly with increasing
the photo-crosslinking energy. It should be noted that the water contents for 7.5% and 10% XRU
hydrogels were not significantly different when crosslinked with a photo energy of 1524 mJ and 2220
mJ, respectively.

These data evidenced that the XRU hydrogels had versatile physicochemical properties, which
promised a wide spectrum of applications for the healing of different types of wound in the body.27
Based on the results and reported Young’s modulus of human skin,28 the XRU hydrogels with Young’
modulus of ~182 kPa (10% (w/v) XRU-MA, 792 mJ photo exposure, denoted as XRU10 hereafter)
12

were selected for the following in vitro study. The morphology of this type of hydrogel, after being
freeze-dried, was examined by SEM, which showed a highly porous microstructure in the cross
section (Fig. 3D and E).

In vitro evaluation of cell-material interactions on the molded XRU10 hydrogels
The XRU10 hydrogels were assessed for cytocompatibility against HDFs, one of the dominant
resident cell types in skin tissue. HDFs cultured on the XRU10 hydrogels demonstrated high cell
viability (Fig. 4A and B). Also, the XRU10 hydrogels supported cell proliferation of HDFs as
demonstrated by a more densely populated cell colony at day 7 compared to day 1. This result proved
the innate cytocompatibility of the XRU10 hydrogels. By contrast, cells barely attached to the alginate
hydrogel, and little cell growth was observed over 7 days (Fig. 4C and D).

Cell proliferation was further quantified by PicoGreen assay. Over 2 weeks’ culture, HDFs grown on
the XRU10 hydrogels showed a 6.3-fold increase in cell number by day 14 (Fig. 4E). By contrast,
alginate hydrogel showed a much smaller number of attached cells at day 1 compared to that of the
XRU10 hydrogel, and the cell number decreased over the culture time. The poor cell attachment and
proliferation of HDFs observed on the alginate hydrogels is due to lack of cell adhesion motifs in
natural alginate and subsequently poor cell-matrix interactions as reported in other studies.19,29,30 The
higher cell proliferation rate observed for the XRU10 hydrogels suggested that these hydrogels may
interact actively with HDFs whereby cell attachment and subsequent cell proliferation took places.
In this context, the reason for improved cell attachment remains to be elucidated, but might be due to
the following two factors. Firstly, the sugar components in XRU, such as L-rhamnose, may facilitate
cell attachment by interacting with HDFs through the cell membrane lectin sites.11 For instance,
Andres et al.31 reported that a rhamnose-rich polysaccharide RROP-1 was able to promote cell
proliferation likely by interacting with the lectin sites present on human skin fibroblasts through the
L-rhamnose moieties. Secondly, the protein component(s) present in the XRU extract may also
13

facilitate cell attachment by providing the cell binding ligands. From this point of view, it is of critical
importance to study a protein-free XRU fraction for a better understanding of the interactions between
HDFs and XRU.

Collagen coating has been widely employed in tissue engineering to improve the initial cell
attachment to synthetic matrices.32 In this study, collagen was coated onto the XRU10 hydrogel by
simply soaking up collagen solution followed by fibrillogenesis at 37 °C. Compared to the pure
XRU10 hydrogels, collagen coating improved cell attachment as demonstrated by a higher cell number
at day 1. Collagen coating further promoted cell proliferation with a 7.5-fold increase in cell number
at day 14 compared to day 1 (Fig. 4E). As a native ECM component, collagen is known to carry cell
adhesion peptides for cell recognition.33,34 The enhanced cell attachment and proliferation could be a
result of improved cell-matrix interactions, thus pointing out a promising approach for further
modification of XRU to improve its biological functions in wound healing applications. Importantly,
the XRU scaffold offers an opportunity for the development on non-contracting collagen based
scaffolds. Collagen hydrogels have been intensively explored in skin tissue engineering and skin
repair.17 However, the force generated by the cultured cells causes severe contraction of the collagen
gel, which would affect the normal healing process, due to insufficient wound covering after
transplantation of the collagen-based structures.35 In this study, the cell-seeded collagen-coated
XRU10 hydrogels did not show any notable dimension change within the period of study, and this
lack of significant contraction was attributable to the ulvan structure.

The organization and distribution of cytoskeletal actin filaments and cellular morphology of HDFs
cultured on the XRU10 hydrogels were examined by F-actin staining and SEM, respectively (Fig. 5).
Fluorescent images revealed that HDFs had densely packed network of actin cytoskeleton yet with
one or two cytoskeletal extensions at day 1, whereas actin filaments were re-organized and distributed
throughout the cellular body that possessed multiple cytoskeletal extensions at day 7 with well visible
14

bundles of actin filaments (Fig. 5A-F). This indicated that HDFs attached to and spread well on the
XRU10 hydrogel. F-actin staining exhibiting the cytoskeleton also revealed the cellular morphologies
of HDFs. Overall, HDFs took on mainly rounded shapes at day 1 and then the typical elongated and
spreading morphologies at day 7. Cell morphology of HDFs visualized by SEM showed rounded cell
shapes at day 1 and well spread and flattened morphologies at day 7, supporting the F-actin staining
results (Fig. 5G-J). These cell behaviors demonstrated that HDFs attached well on the XRU10
hydrogel and achieved full spreading with extended culture time. This may provide a foundation for
the observed high cell proliferation rate of HDFs cultured on the XRU10 hydrogels, and substantiated
the potential of the XRU-based hydrogel for promoting cell attachment and spreading of HDFs.

Fabrication of (cell-containing) XRU-based constructs by extrusion printing
For 3D printing XRU10 hydrogels, a composite ink comprising 10% (w/v) XRU-MA and 5% (w/v)
gelatin was prepared. The XRU-MA solution on its own behaved like a runny liquid, so gelatin was
added to improve its printability. Gelatin has often been used in bioink formulation for 3D printing,
and this is attributable to its thermo-responsive gelation behavior.36 The thermo-gelling property of
gelatin provides a means to engineer the viscoelastic properties and hence the printability of its
containing inks. Further, gelatin has also been used as a sacrificial material in 3D printing as it can
be readily removed post-printing.36,37 Fig. 6A shows the temperature sweep of the storage moduli
(G’) and loss moduli (G’’) of the composite ink. Both G’ and G’’ increased with reducing temperature
and crossed at ~23 °C as a result of temperature (T) induced sol-gel transition. When T > 23 °C, G’
was less than G’’, indicating the presence of a viscous liquid. When T ≤ 23 °C, G’ was greater than
G’’, indicating the presence of a viscoelastic solid. In this study, 23 °C was selected for extrusion
printing as the ink behaved like a soft gel, which allowed it to be extruded as a consistent fiber. The
ink was extruded onto a colder substrate at 15 °C to help retain the printed structure. G’ at 15 °C was
~350 Pa, whereby the ink behaved more solid-like and was capable of retaining shape before photocrosslinking.38
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One key property that an ink should have for extrusion printing is shear-thinning. This was assessed
here by performing the shear rate sweeps at 23 °C and a lower temperature of 15 °C, respectively
(Fig. 6B). Fig. 6B shows that the ink exhibited a non-Newtonian, shear-thinning behavior as the
polymer network aligned with a high shear stress present. The shear-thinning behavior can be
described by the power-law model (the Ostwald-de Waele Model) as shown in Equation (4).39 The
flow behavior index, n, was determined to be 0.328 and 0.176 for the ink at 23 °C and 15 °C
respectively, by fitting the viscosity-shear rate curve with the power-law model.

𝜂 = 𝐾𝛾̇n-1

(4)

where 𝜂 is viscosity (Pa s), 𝛾̇ is shear rate (s-1), and K is the flow consistency index (viscosity at a
shear rate of 1 s-1).

When a non-Newtonian power-law fluid flows in a cylinder tube such as an extrusion needle,
according to the law of the wall, the fluidic portion near the wall of the tube moves the slowest and
is subjected to the highest shear rate, when compared to the faster moving portion in the middle of
the tube.39 To estimate the maximum shear rate that the ink experienced during extrusion printing,
i.e. the shear rate at the needle wall, the Rabinowitsch-Mooney equation was utilized as shown
below.40

𝛾̇ = (3n+1)Q/(nπr3)

(5)

where n is the flow behavior index, Q is the volumetric flow rate (mm³ s-1) and r is the radius of the
extrusion needle (mm). For extrusion at 23 °C, with a 200 µm needle diameter and an extrusion rate
of 10 mm s-1 (Q = π · (0.1 mm)² · 10 mm s-1 ≈ 0.314 mm³ s-1), the maximum shear rate during
extrusion printing was estimated to be 604.9 s-1, which correlated to a viscosity of ~0.7 Pa s.
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Immediately after the extrusion, the bioink experienced negligible shear rates (≤ 0.1 s-1), and came
into contact with the cold substrate at 15 °C. Assuming a shear rate of 0.1 s−1, the corresponding
viscosity of the ink was ~1070.7 Pa s when touching the 15 °C substrate, which was significantly
higher than the one during the extrusion printing. The low viscosity during extrusion (~0.7 Pa s)
enabled the smooth and continuous flow of the ink through the needle, while the high viscosity
(~1070.7 Pa s) allowed it to maintain its shape after the extrusion.41 These data were in good
agreement with those reported in the literature. Generally, the empirical ink viscosities for extrusion
printing have been reported to range from 0.3 to 30 Pa s at the high shear rates (102-103 s-1) during
extrusion, and range from 102 to 103 Pa s at the low shear rates of ≤ 0.1 s-1.38,40-43

The XRU-based ink was tested firstly for 3D printing cell-free macroporous scaffolds. The 3D printed
structures were stabilized by photo-crosslinking upon printing, and then incubated in the culture
medium at 37 °C to remove the entrapped gelatin. As shown in Fig. 7A, the 3D-printed XRU scaffolds
have an average strut width of 180 ± 24 µm and pore size of 1022.0 ± 51.6 µm. As with the molded
XRU hydrogels, the 3D printed XRU scaffolds supported HDF attachment with high cell viability
(Fig. 7B and C) and proliferation over a period of 2 weeks (Fig. 7D). This is quantitatively
demonstrated by a PicoGreen assay that showed a 10.1-fold increase in the cell number by day 14
(Fig. 7D). The bioink was also assessed for 3D printing cell-laden structures. The 3D-printed HDFsembedded constructs showed high cell viability over a period of 7 days (Fig. 7E and F). However,
the encapsulated cells exhibited rounded morphologies even at day 7 with minimal cell growth. This
is probably due to the formation of a densely packed polymer network which may impede to some
extent cell-matrix interactions and cell metabolic activities. Our work demonstrates a highly
cytocompatible nature of 3D printed XRU-based hydrogels as structural support. Optimization of the
XRU ink formulation for direct cell printing is currently being undertaken in parallel with in-depth
biological characterization, to understand the effects of scaffold structure on the functions of
encapsulated HDFs at the molecular level.
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The cell work presented here using HDF represents a first biologically relevant step to test the
biocompatibility and safety of the biomaterial in wound healing. Future studies should focus on in
vitro characterizations to understand the role of ink formulation in dermal ECM secretion, and
subsequent optimization of 3D printing to produce skin like structures that imitate the cellular
organization and functions of native skin. In vivo characterizations are equally important to assess
tissue compatibility of the material firstly and then wound healing capacity of 3D printed cellular
constructs.

Conclusions
In this study we present the functionalization of a rhamnose-rich xylorhamno-uronic acid (XRU)
extract in the context of wound healing. The XRU extract was methacrylated and XRU-based
hydrogels were prepared via photo-crosslinking of the incorporated methacrylate groups. XRU-based
hydrogels demonstrated high water uptake capacity and tuneable mechanical properties. The gels
were found to be highly cytocompatible with high cell viability and supported cell attachment and
cell proliferation when tested with HDFs. An XRU-based bioink has been formulated for enabling
controlled fabrication of 3D XRU structures via extrusion printing both with and without cells. The
3D printed hydrogel scaffolds displayed high cytocompatibility with HDFs. These results highlight
the potential of this sulfated, rhamnose-rich XRU extract as a promising biomaterial for dermal
matrix, which provides a foundation for our ongoing research to develop marine-based bioprinting
platforms for skin repair and regeneration.
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Tables
Table 1 The proximate composition and key characteristics of xylorhamno-uronic acid (XRU) extract
shown as wt. % of dry weight and elemental analysis.
Chemical components

XRU extract

Protein

13.2 ± 0.2%

L-rhamnose

47.5 ± 2.5%

Rhamnose:xylose

5-7

Total uronic acid

15.9 ± 0.4%

Sulfate

16.9 ± 0.4%

Elemental analysis
C

31.1 ± 0.2%

N

3.6 ± 0.2%

S

5.6 ± 0.1%
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Figure Legends
Fig. 1 Ulvans share a high structural similarity to mammalian glycosaminoglycans found in human
skin, due to the presence of uronic acid units and sulfate groups.
Fig. 2 Structural characterization of XRU and XRU-MA: (A) Schematic representation of the XRU
methacrylation; (B) FT-IR spectra confirmed the successful modification by the additional peak at
~1713 cm-1 in XRU-MA; (C) 1H NMR spectra obtained at 60 °C confirmed the successful conjugation
of the methacrylate groups. The proton(s) confined in boxes as shown in the formulae of XRU
disaccharide repeating unit (denoted by a, b, c and d, respectively) were marked in individual
spectrum.
Fig. 3 Physicochemical properties of the molded XRU hydrogels: (A) XRU hydrogels showed
tuneable mechanical properties with Young’s moduli in a range of ~18-309 kPa by varying polymer
concentration and photo exposure energy; (B) XRU hydrogels had high water uptake capacity
(~3000-8000%) after 24 h hydration and reached the equilibrium water content within 3 hours; (C)
XRU hydrogels showed a high water content of > 96% after 24 h hydration; (D,E) Representative
images showing the microstructure of the cross section of the XRU10 hydrogels (10% (w/v) XRUMA, 792 mJ). E is the higher magnification of the confined area in D. * indicates p < 0.05 and **
indicates p < 0.001.
Fig. 4 HDFs cultured on XRU10 hydrogels (10% XRU-MA, 792 mJ) after (A) 1 and (B) 7 days, and
on alginate hydrogels after (C) 1 and (D) 7 days. Calcein AM/PI were used to stain live (green) and
dead (red) cells, respectively. (E) Cell proliferation of HDFs on varying hydrogels including alginate,
XRU10, and collagen-coated XRU10 (Col-XRU10) hydrogels by PicoGreen assay. * indicates p < 0.05
and ** indicates p < 0.001.
Fig. 5 Cell morphology of HDFs cultured on the XRU10 hydrogels (10% XRU-MA, 792 mJ) at day
1 (A-C, G-H) and day 7 (D-F, I-J) characterized by F-actin staining (A-F) and SEM (G-J),
respectively. A & D: nuclei (blue); B & E: F-actin (green); C: merged image of A and B; F: merged
image of D and E. H and J is the higher magnification of the confined area in G and I, respectively.
Cells were highlighted by the yellow arrows in G-J.
Fig. 6 Rheological behavior of the XRU-MA/gelatin bioink demonstrated thermo-responsive phase
change behavior (A) and shear-thinning property measured at 23 °C and 15 °C, respectively (B).
Fig. 7 Fabrication of (cell-containing) XRU-based constructs by extrusion printing: (A) A
representative image of the 3D-printed XRU-based structures; (B, C) Representative live/dead
staining images of human dermal fibroblasts (HDFs) cultured in the 3D-printed scaffolds at day 1 and
day 7, respectively; (D) Cell proliferation of HDFs cultured in the prefabricated XRU hydrogels by
PicoGreen assay. * indicates p < 0.05 and ** indicates p < 0.001; (E, F) Representative live/dead
staining images of the 3D printed HDFs in the XRU hydrogels after day 1 (E) and day 7 (F) in culture.
Inset image shows magnified live/dead staining from the same image. Living cells were stained green
and dead cells red.
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Graphic abstract
3D printing of sulphated, rhamnose-rich hydrogels, using a seaweed extract from a controlled
source of Australian ulvacean macroalgae, for wound healing.
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